首页> 外文期刊>International Journal of Cardiology >Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties
【24h】

Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties

机译:由于抗炎和抗纤维化特性,慢性低剂量松弛素免受实验性心肌梗死的心律失常

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The peptide hormone relaxin-2 (RLX) exerts beneficial effects during myocardial ischemia, but functional data on lower-dose RLX in myocardial infarction (MI) is lacking. Therefore, we investigated the impact of 75 mu g/kg/d RLX treatment on electrical vulnerability and left ventricular function in a mouse model of MI.
机译:背景:肽激素弛豫素-2(RLX)在心肌缺血期间施加有益效果,但缺乏关于心肌梗死(MI)的低剂量RLX的功能数据。 因此,我们研究了在MI小鼠模型中对75μg/ kg / d rlx治疗对电脆性和左心室功能的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号